Case Report of Malignancy-Hemophagocytic Lymphohistiocytosis: A Dangerous and Rare Sepsis Mimic

We describe a 66-year-old woman with a history of stage IV breast cancer that presented with multiple admissions for unresolved septic-like presentations. Due to the high clinical suspicion and HLH-2004 criteria, HLH was placed on the differential and further testing revealed a new-onset lymphoma. Treatment was eventually initiated to suppress the hyperinflammatory state of M-HLH and to target the new-onset stage IVB pleomorphic mantle cell lymphoma. Even though treatment was delayed, the patient survived for multiple months longer than the median survival rate. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Emergency physicians should be aware of M-HLH due the hyperaggressive nature of this disease and its elusive presentation; often mimicking common emergency department presentations such as sepsis. The role of the emergency physician should be to stabilize the patient, assess red flags, identify HLH on the differential, and consult with the hematology/oncology service for further testing and potential early treatment.

Authors

Institutions

Publication Details

Journal
Journal of Emergency Medicine
Published
2026-01-08
DOI
https://doi.org/10.1016/j.jemermed.2025.12.029
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report of Malignancy-Hemophagocytic Lymphohistiocytosis: A Dangerous and Rare Sepsis Mimic

Christopher J. Coyne, Rishi K Gupta
Journal of Emergency Medicine
Autoimmune and Inflammatory Disorders Research
article

Case Report of Malignancy-Hemophagocytic Lymphohistiocytosis: A Dangerous and Rare Sepsis Mimic

Christopher J. Coyne, Rishi K Gupta
article en

Abstract

We describe a 66-year-old woman with a history of stage IV breast cancer that presented with multiple admissions for unresolved septic-like presentations. Due to the high clinical suspicion and HLH-2004 criteria, HLH was placed on the differential and further testing revealed a new-onset lymphoma. Treatment was eventually initiated to suppress the hyperinflammatory state of M-HLH and to target the new-onset stage IVB pleomorphic mantle cell lymphoma. Even though treatment was delayed, the patient survived for multiple months longer than the median survival rate. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Emergency physicians should be aware of M-HLH due the hyperaggressive nature of this disease and its elusive presentation; often mimicking common emergency department presentations such as sepsis. The role of the emergency physician should be to stabilize the patient, assess red flags, identify HLH on the differential, and consult with the hematology/oncology service for further testing and potential early treatment.

Journal of Emergency MedicineVol. 82
Kansas City University (US), University of San Diego (US), University of California San Diego (US)
Good health and well-being
Openalex Percentile: Top 95%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.